Safety, efficacy and lessons from continuous infusion with rFVIIa

被引：71

作者：

Schulman, S ^{[1
]}

机构：

[1] Karolinska Hosp, Coagulat Unit, Dept Med, S-17176 Stockholm, Sweden

来源：

HAEMOPHILIA | 1998年 / 4卷 / 04期

关键词：

activated factor VII; haemophilia; inhibitor; continuous infusion;

D O I：

10.1046/j.1365-2516.1998.440564.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Continuous infusion with coagulation factor concentrates has only been widely adapted during the last decade and with recombinant activated factor VII (rFVIIa) only during the last 2 years. Still the accumulated number of days on continuous infusion with this product amounts by now to more than one year, 35 patients and 26 surgical procedures. The experience is reviewed here and compared with data from the conventional bolus dose regimen.

引用

页码：564 / 567

页数：4

共 13 条

[1]

Hedner U, 1996, HAEMOSTASIS, V26, P102

[2]

HEDNER U, 1988, LANCET, V2, P1193

[3]

Ingerslev J, 1996, HAEMOSTASIS, V26, P118

[4] PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT FACTOR VIIA [J].

LINDLEY, CM ;

SAWYER, WT ;

MACIK, BG ;

LUSHER, J ;

HARRISON, JF ;

BAIRDCOX, K ;

BIRCH, K ;

GLAZER, S ;

ROBERTS, HR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (06) :638-648

[5]

Lusher JM, 1996, HAEMOSTASIS, V26, P124

[6]

MAKRIS M, 1990, CLIN USE ACTIVATED R, pO32

[7]

Martinowitz U, 1994, INT J PEDIAT HEMATOL, V1, P471

[8] CONTINUOUS INTRAVENOUS INFUSION OF FACTOR-8 IN CLASSIC HAEMOPHILIA [J].

MCMILLAN, CW ;

WEBSTER, WP ;

ROBERTS, HR ;

BLYTHE, WB .

BRITISH JOURNAL OF HAEMATOLOGY, 1970, 18 (06) :659-+

[9]

Schulman S, 1996, THROMB HAEMOSTASIS, V75, P432

[10]

SCULMAN S, UNPUB BLOOD COAG FIB

← 1 2 →